When does NUCANA PLC-ADR (NCNA) report earnings?
NUCANA PLC-ADR (NCNA) will report earnings on 2026-06-01.
NUCANA PLC-ADR (NCNA) Forecast, Price Target & Analyst Ratings
NASDAQ:NCNA • US67022C3043
Current stock price
1.53 USD
-0.06 (-3.77%)
At close:
1.49 USD
-0.04 (-2.61%)
Pre-Market:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NUCANA PLC-ADR (NCNA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Jun 1, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -£3.32
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $1.53 to mean target of N/A, Based on 8 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.50%
NCNA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NCNA.
In the previous month the buy percentage consensus was at a similar level.
NCNA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-09-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-30 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-08-19 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-07-23 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-07-22 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-01 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-11-21 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-09-06 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-08-18 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-05-22 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2022-09-22 | Jefferies | Maintains | Buy |
| 2022-03-03 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2021-11-24 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Jun 1, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -£3.32
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- -74.51%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
NCNA is expected to report earnings on 6/1/2026. The consensus EPS estimate for the next earnings is -3.31 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2025 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A -100.00% | N/A | N/A 66.67% | N/A 45.00% | N/A 31.04% | |||||||||||
| EBITDA YoY % growth | -6.862M | -8.946M -30.37% | -22.052M -146.50% | -21.659M 1.78% | -24.942M -15.16% | -32.033M -28.43% | -44.403M -38.62% | -42.964M 3.24% | -30.521M 28.96% | -22.466M 26.39% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.906M | -9.047M -31.00% | -22.246M -145.89% | -22.03M 0.97% | -25.66M -16.48% | -32.923M -28.30% | -45.345M -37.73% | -43.696M 3.64% | -31.096M 28.84% | -22.988M 26.07% | N/A -23.06% | N/A 2.87% | N/A -15.33% | N/A -125.82% | N/A 72.09% | N/A 250.00% | N/A 200.00% | N/A 55.55% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2,150.00 -73.96% | -3,350.00 -55.81% | -3,950.00 -17.91% | -3,600.00 8.86% | -3,050.00 15.28% | -2,600.00 14.75% | N/A 99.57% | N/A 34.00% | N/A 83.62% | N/A -113.35% | N/A 78.12% | N/A -1,654.05% | N/A 225.15% | N/A 159.97% | N/A 38.41% |
All data in GBP
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -3.32 -74.51% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -8.772M -591.25% |
All data in GBP
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
20.95%
EPS Next 5 Year
2.20%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
NUCANA PLC-ADR / NCNA Forecast FAQ
What are the consensus estimates for NUCANA PLC-ADR (NCNA) next earnings?
The consensus EPS estimate for the next earnings of NUCANA PLC-ADR (NCNA) is -3.31 USD and the consensus revenue estimate is 0 USD.
How do analysts rate NUCANA PLC-ADR (NCNA)?
The consensus rating for NUCANA PLC-ADR (NCNA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.